Brain tumor incidence is on the rise, and glioblastoma comprises majority of primary tumors. Despite maximal safe resection adjuvant chemoradiation, median survival for high-grade glioma remains poor. For this reason, it important to develop incorporate new treatment strategies. Oncolytic virotherapy has emerged as a viable therapeutic entity fill gap. Preclinical research shown oncolytic be ro...